<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB"><gtr:id>AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB</gtr:id><gtr:name>Oxford University Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Churchill Site</gtr:line1><gtr:line2>Old Road</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 7LJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C1CE3B13-A79B-48B7-9B8D-97BC9C07DC78"><gtr:id>C1CE3B13-A79B-48B7-9B8D-97BC9C07DC78</gtr:id><gtr:name>Netherlands Cancer Institute</gtr:name><gtr:address><gtr:line1>Plesmanlaan 121</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/89F66D08-390A-4D3A-9C7C-6780F6F7A1AC"><gtr:id>89F66D08-390A-4D3A-9C7C-6780F6F7A1AC</gtr:id><gtr:name>University of Southern Denmark</gtr:name><gtr:address><gtr:line1>Campusvej 55</gtr:line1><gtr:line4>Odense M</gtr:line4><gtr:postCode>DK-5230</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/53FF1E0F-4CEA-45F1-A226-C6B9255FEF0E"><gtr:id>53FF1E0F-4CEA-45F1-A226-C6B9255FEF0E</gtr:id><gtr:name>Danish Breast Cancer Cooperative Group (DBCG)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB"><gtr:id>AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB</gtr:id><gtr:name>Oxford University Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Churchill Site</gtr:line1><gtr:line2>Old Road</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 7LJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C1CE3B13-A79B-48B7-9B8D-97BC9C07DC78"><gtr:id>C1CE3B13-A79B-48B7-9B8D-97BC9C07DC78</gtr:id><gtr:name>Netherlands Cancer Institute</gtr:name><gtr:address><gtr:line1>Plesmanlaan 121</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/89F66D08-390A-4D3A-9C7C-6780F6F7A1AC"><gtr:id>89F66D08-390A-4D3A-9C7C-6780F6F7A1AC</gtr:id><gtr:name>University of Southern Denmark</gtr:name><gtr:address><gtr:line1>Campusvej 55</gtr:line1><gtr:line4>Odense M</gtr:line4><gtr:postCode>DK-5230</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/53FF1E0F-4CEA-45F1-A226-C6B9255FEF0E"><gtr:id>53FF1E0F-4CEA-45F1-A226-C6B9255FEF0E</gtr:id><gtr:name>Danish Breast Cancer Cooperative Group (DBCG)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/FA3B00B7-4EF5-4538-B668-47F9FD0B1481"><gtr:id>FA3B00B7-4EF5-4538-B668-47F9FD0B1481</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Cutter</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3434EFD8-9DAC-49B9-9981-FD875519A53E"><gtr:id>3434EFD8-9DAC-49B9-9981-FD875519A53E</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Peto</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E6AF17E4-1264-4FFA-BABC-59C2D02BF1E1"><gtr:id>E6AF17E4-1264-4FFA-BABC-59C2D02BF1E1</gtr:id><gtr:firstName>Simon</gtr:firstName><gtr:surname>Read</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A82113BA-90B1-4A69-80A1-85994CE76628"><gtr:id>A82113BA-90B1-4A69-80A1-85994CE76628</gtr:id><gtr:firstName>Katherine</gtr:firstName><gtr:surname>Henson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0EBBF980-6B76-470B-87FD-64B300CB48E7"><gtr:id>0EBBF980-6B76-470B-87FD-64B300CB48E7</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>A</gtr:otherNames><gtr:surname>McGale</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A831E6E2-A2B8-4D4B-996D-0E21E70604EF"><gtr:id>A831E6E2-A2B8-4D4B-996D-0E21E70604EF</gtr:id><gtr:firstName>Johanna</gtr:firstName><gtr:otherNames>C</gtr:otherNames><gtr:surname>Rankin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/88142642-B720-47A1-ADDA-5DE187A5D17B"><gtr:id>88142642-B720-47A1-ADDA-5DE187A5D17B</gtr:id><gtr:firstName>Gurdeep</gtr:firstName><gtr:otherNames>Singh</gtr:otherNames><gtr:surname>Mannu</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6C344ACA-7EAB-4E64-8F77-6BB215F0C483"><gtr:id>6C344ACA-7EAB-4E64-8F77-6BB215F0C483</gtr:id><gtr:firstName>Sarah</gtr:firstName><gtr:surname>Darby</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E3786A6C-3899-4884-B344-E1FC185F3EE8"><gtr:id>E3786A6C-3899-4884-B344-E1FC185F3EE8</gtr:id><gtr:firstName>Zhe</gtr:firstName><gtr:surname>Wang</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/64C7D393-B269-43A1-B2FE-55039A2E74DA"><gtr:id>64C7D393-B269-43A1-B2FE-55039A2E74DA</gtr:id><gtr:firstName>Carolyn</gtr:firstName><gtr:otherNames>Wendy</gtr:otherNames><gtr:surname>Taylor</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/704B63DB-C4BA-460F-84CE-AA198DE675D8"><gtr:id>704B63DB-C4BA-460F-84CE-AA198DE675D8</gtr:id><gtr:firstName>Frances</gtr:firstName><gtr:otherNames>K</gtr:otherNames><gtr:surname>Duane</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/34C81673-ED61-41DB-B162-28347F638C60"><gtr:id>34C81673-ED61-41DB-B162-28347F638C60</gtr:id><gtr:firstName>Amanda</gtr:firstName><gtr:surname>Kerr</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U137686858"><gtr:id>629B9DBA-1856-4551-A962-D1EEEA983CD1</gtr:id><gtr:title>Assessment of the benefits and risks of cancer treatments</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U137686858</gtr:grantReference><gtr:abstractText>Most people who get cancer now survive and this is in large part due to the effectiveness of treatments, such as chemotherapy and radiotherapy, and in the UK alone there are estimated to be over 2 million people who are cancer survivors. While the short term side effects of such treatments are well known, the long term health effects of these treatments were largely unknown. Our programme of research has previously demonstrated that radiotherapy treatment increases the long-term risk of heart disease in cancer patients and this has resulted in changes in clinical practice, such as taking measures to minimise the exposure of the heart to radiotherapy during treatment and also treating with lower doses of radiotherapy. This research allows clinicians to individualise the dose of radiotherapy given to each patient to maximise the benefit and minimise the long-term risk of heart disease. Our current research is looking in more detail at these risks from radiotherapy as well as collaborating with many other scientists worldwide to better understand the risks of various other treatments, such as anthracyclines. We are also carrying out research to better understand the long-term risks, particularly from heart disease, of cancer treatments in children, teenagers and young adults.</gtr:abstractText><gtr:technicalSummary>The programme will continue a long-running area of research to produce uniquely reliable answer to important clinical questions concerned with the benefits and the main risks of treatments for various cancers, which includes breast cancer, lymphomas and all cancers diagnosed in children, teenagers and young adults. All currently available treatments have both short term side-effects, which are generally well documented, as well as less well studied long-term hazards. For example, our previous research has developed a dose-response relationship for use by clinicians to predict the radiation-related ischaemic heart disease risk for individual women irradiated for breast cancer, based on their cardiac radiation dose and their pre-existing risk factors. Our future work will further develop these risk/benefit prediction models to include valvular heart disease and pericarditis in breast cancer radiotherapy and for ischaemic heart disease, valvular heart disease, and heart failure in Hodgkin lymphoma radiotherapy. In addition, we will bring together the results from a number of treatment trials of anthracyclines for various cancers to reliably determine the risks of cardiovascular disease from these therapies. We will also analyse several large cohorts to more precisely determine the risk of cardiovascular disease from various cancer treatments using data from cancer registries that include around 2 million women with breast cancer and also determine these risks in children, teenagers and young adults using UK data on around 250,000 cancer survivors.</gtr:technicalSummary><gtr:fund><gtr:end>2016-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>841318</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford University Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Clinical Collaborations within Oxford</gtr:description><gtr:id>E40942B1-4825-4A18-9662-D5318E9362F7</gtr:id><gtr:impact>The collaboration involves oncologists, physicists, surgeons and radiographers. Outputs from these collaborations include:
Audit of Cardiac dose from tangential breast cancer radiotherapy in the year 2010 C.W. Taylor (2010)
Lorenzen EL, Taylor CW, Maraldo M, Nielsen MH, Offersen BV, Andersen MR, O'Dwyer D, Larsen L, Duxbury S, Jhitta B, Darby SC, Ewertz M, Brink C. Inter-observer variation in delineation of the heart and left anterior descending coronary artery in radiotherapy for breast cancer: A multi-centre study from Denmark and the UK. Radioth Oncol 2013;108:254-258.
Taylor CW, Wang Z, Macaulay E, Jagsi R, Darby SC. Exposure of the heart in breast cancer radiotherapy: A systematic review of heart doses published during 2003-2013. Int J Radiat Oncol Biol Phys 2015;93:845-853.</gtr:impact><gtr:outcomeId>58ba83d60f9ce4.06962815-1</gtr:outcomeId><gtr:partnerContribution>Collaboration with oncologists, radiographers, physicists and surgeons has enabled the team to ensure that their research programme answers clinically relevant question, and remains up to date</gtr:partnerContribution><gtr:piContribution>Dr Carolyn Taylor and Dr Frances Duane are collaborating with other breast oncologists to develop internal mammary nodal radiotherapy
Dr David Cutter is collaborating with lymphoma oncologists to improve lymphoma radiotherapy
Dr Marianne Aznar collaborates with radiotherapy physicists 
Mr Gurdeep Mannu collaborates with breast surgeons
All four individuals are involved in teaching in Oxford University Hospitals NHS Trust</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Netherlands Cancer Institute (NKI)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Academic Collaborators</gtr:description><gtr:id>DDBA8E83-D8D0-4B7C-8B1C-2E3FECD8B452</gtr:id><gtr:impact>Our research is making a significant contribution to the development of several clinical tools used by oncologists to predict the absolute benefits of various breast cancer treatments.</gtr:impact><gtr:outcomeId>542e8428da65d0.94794451-5</gtr:outcomeId><gtr:partnerContribution>Academic partners provide various datasets for our analyses and help to formulate and develop future research questions.</gtr:partnerContribution><gtr:piContribution>CTSU co-ordinates data collection from a number of national and international partners, including other academic institutions and cancer registries. This disparate data is then cleaned, entered into a study database in order to undergo statistical analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Netherlands Cancer Institute (NKI)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Molecular Pathology Division</gtr:department><gtr:description>Collaboration with Netherlands Cancer Institute to study the risk of colorectal cancer after radiotherapy for Hodgkin lymphoma</gtr:description><gtr:id>DFF318F2-EE5A-4948-A27E-13A80223708C</gtr:id><gtr:impact>doi: https://doi.org/10.1182/blood-2016-09-740332</gtr:impact><gtr:outcomeId>58bd4bb91ac556.87492755-1</gtr:outcomeId><gtr:partnerContribution>NKI staff have obtained information regarding patients treated at the NKI and other hospitals in the Netherlands, obtaining information on treatments received, risk factors for heart disease and outcomes</gtr:partnerContribution><gtr:piContribution>We have provided expertise in dosimetry and in statistical analysis</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Southern Denmark</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:department>Department of Oncology</gtr:department><gtr:description>Academic Collaborators</gtr:description><gtr:id>5A883BCC-8F15-4DE6-BC9D-E7FA153AFDDA</gtr:id><gtr:impact>Our research is making a significant contribution to the development of several clinical tools used by oncologists to predict the absolute benefits of various breast cancer treatments.</gtr:impact><gtr:outcomeId>542e8428da65d0.94794451-1</gtr:outcomeId><gtr:partnerContribution>Academic partners provide various datasets for our analyses and help to formulate and develop future research questions.</gtr:partnerContribution><gtr:piContribution>CTSU co-ordinates data collection from a number of national and international partners, including other academic institutions and cancer registries. This disparate data is then cleaned, entered into a study database in order to undergo statistical analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>CRUK/MRC Oxford Institute for Radiation Oncology</gtr:department><gtr:description>Academic Collaborators</gtr:description><gtr:id>92AD2874-FCC8-45EA-970F-A9E2BB06A3DE</gtr:id><gtr:impact>Our research is making a significant contribution to the development of several clinical tools used by oncologists to predict the absolute benefits of various breast cancer treatments.</gtr:impact><gtr:outcomeId>542e8428da65d0.94794451-3</gtr:outcomeId><gtr:partnerContribution>Academic partners provide various datasets for our analyses and help to formulate and develop future research questions.</gtr:partnerContribution><gtr:piContribution>CTSU co-ordinates data collection from a number of national and international partners, including other academic institutions and cancer registries. This disparate data is then cleaned, entered into a study database in order to undergo statistical analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Big data in populations of cancer patients</gtr:description><gtr:id>A39FE2C6-BA6F-493F-AFA7-F1936BE5BE2E</gtr:id><gtr:impact>None so far</gtr:impact><gtr:outcomeId>58bd7de1beb200.72499252-1</gtr:outcomeId><gtr:partnerContribution>Public Health England have provided us with data on all 600,000 women diagnosed with breast cancer in England during 1997-2014. Items included are patient and tumour characteristics and, for those who have died, the date and cause of death.</gtr:partnerContribution><gtr:piContribution>We are developing models to predict the benefits and risks from the various different options available for treating women who have been diagnosed with breast cancer. During the course of this we are also helping Public Health England to improve the quality of their routine data.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford University Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Radiotherapy Physics</gtr:department><gtr:description>Academic Collaborators</gtr:description><gtr:id>1B97F6FA-2EB4-4A7D-9DD2-E9241F53482A</gtr:id><gtr:impact>Our research is making a significant contribution to the development of several clinical tools used by oncologists to predict the absolute benefits of various breast cancer treatments.</gtr:impact><gtr:outcomeId>542e8428da65d0.94794451-6</gtr:outcomeId><gtr:partnerContribution>Academic partners provide various datasets for our analyses and help to formulate and develop future research questions.</gtr:partnerContribution><gtr:piContribution>CTSU co-ordinates data collection from a number of national and international partners, including other academic institutions and cancer registries. This disparate data is then cleaned, entered into a study database in order to undergo statistical analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Danish Breast Cancer Cooperative Group (DBCG)</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>Academic Collaborators</gtr:description><gtr:id>4C2E9E13-6CAD-4B81-9504-D37C69F79B2C</gtr:id><gtr:impact>Our research is making a significant contribution to the development of several clinical tools used by oncologists to predict the absolute benefits of various breast cancer treatments.</gtr:impact><gtr:outcomeId>542e8428da65d0.94794451-2</gtr:outcomeId><gtr:partnerContribution>Academic partners provide various datasets for our analyses and help to formulate and develop future research questions.</gtr:partnerContribution><gtr:piContribution>CTSU co-ordinates data collection from a number of national and international partners, including other academic institutions and cancer registries. This disparate data is then cleaned, entered into a study database in order to undergo statistical analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Oncology</gtr:department><gtr:description>Academic Collaborators</gtr:description><gtr:id>C3786650-4879-4209-BDBB-FD8E58C1D454</gtr:id><gtr:impact>Our research is making a significant contribution to the development of several clinical tools used by oncologists to predict the absolute benefits of various breast cancer treatments.</gtr:impact><gtr:outcomeId>542e8428da65d0.94794451-4</gtr:outcomeId><gtr:partnerContribution>Academic partners provide various datasets for our analyses and help to formulate and develop future research questions.</gtr:partnerContribution><gtr:piContribution>CTSU co-ordinates data collection from a number of national and international partners, including other academic institutions and cancer registries. This disparate data is then cleaned, entered into a study database in order to undergo statistical analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Childhood Cancer Survivor Studies</gtr:department><gtr:description>Academic Collaborators</gtr:description><gtr:id>A43A35A7-D81B-45B3-A01D-0A32ABC64E82</gtr:id><gtr:impact>Our research is making a significant contribution to the development of several clinical tools used by oncologists to predict the absolute benefits of various breast cancer treatments.</gtr:impact><gtr:outcomeId>542e8428da65d0.94794451-7</gtr:outcomeId><gtr:partnerContribution>Academic partners provide various datasets for our analyses and help to formulate and develop future research questions.</gtr:partnerContribution><gtr:piContribution>CTSU co-ordinates data collection from a number of national and international partners, including other academic institutions and cancer registries. This disparate data is then cleaned, entered into a study database in order to undergo statistical analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Netherlands Cancer Institute (NKI)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Molecular Pathology Division</gtr:department><gtr:description>Pathological study of DCiS</gtr:description><gtr:id>2F19626E-AF01-42BB-A6FC-55346F5ADAFF</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:outcomeId>58bd4d070986a3.94748568-1</gtr:outcomeId><gtr:partnerContribution>Data regarding women diagnosed with DCIS at the NKI and other hospitals in the Netherlands, including pathological and radiological information.</gtr:partnerContribution><gtr:piContribution>Study design, statistical analysis</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Media coverage following NEJM publication: increase in heart disease risk following radiotherapy treatment for cancer</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B53FF92B-83FE-43C6-9ECD-3F6DD54D26B5</gtr:id><gtr:impact>US CBS news website: http://www.cbsnews.com/news/radiation-for-breast-cancer-may-raise-heart-disease-risk-for-women/


Increased awareness amongst patients and oncologists of the increased risk of heart disease in cancer patients who receive radiotherapy.</gtr:impact><gtr:outcomeId>543544d69d2e26.06721979</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Twitter journal club</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B9B4ACB6-FC61-412E-8164-1F012A7FA431</gtr:id><gtr:impact>The following publication was the subject of a twitter journal club on 24th January 2016. Taylor, CW, Kirby AM. Cardiac side-effects from breast cancer radiotherapy. Clin Oncol 2015;27:621-9.
It had participation from the USA, Canada, Australia, Singapore, Saudi, UK and Spain

During the day there 465,000 page impressions (ie delivered tweets). Over the week that we first mentioned the journal club there were 1.6 million page impressions with 616 tweets from 180 participants with a big surge over Sunday 24th January</gtr:impact><gtr:outcomeId>56d5bd76724bb9.75128277</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>382000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research grant</gtr:description><gtr:end>2015-11-02</gtr:end><gtr:fundingOrg>Department of Health (DH)</gtr:fundingOrg><gtr:id>62718759-3D2C-449E-AC2F-AD5A1A3639E5</gtr:id><gtr:outcomeId>5432bb0fb9c216.50245774</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>449000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research grant</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>Department of Health (DH)</gtr:fundingOrg><gtr:id>E4860C54-E6EE-4F0E-BA4B-826A00B9552F</gtr:id><gtr:outcomeId>5432baa08d31e7.45717305</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research grant</gtr:description><gtr:end>2011-02-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>A7A68716-6948-4736-8A7B-75BD248DD759</gtr:id><gtr:outcomeId>5432b827c0f595.44535092</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>187000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Research Training</gtr:description><gtr:end>2012-08-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>578D5D0A-B67F-4BD0-AD67-C3D2CF747DB1</gtr:id><gtr:outcomeId>5432b9d52e7ab0.16573519</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>49000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Excellence Award</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>FC940365-4A0C-46CC-99BD-0BDCA9816523</gtr:id><gtr:outcomeId>5432ba2db12937.00456952</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3207422</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Programme Grant Award</gtr:description><gtr:end>2021-03-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>8B0DB32B-D6A1-4160-9725-3C5B713503C1</gtr:id><gtr:outcomeId>56d9ae2781a235.40440266</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>71000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Non-Clinical Training</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>6F7DA135-130B-4185-9178-221A0E93F846</gtr:id><gtr:outcomeId>5432b8cc4da244.10104478</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>258000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research grant (RACE)</gtr:description><gtr:end>2009-10-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>A88E11C4-F414-4F7F-89F2-7279DD9547DB</gtr:id><gtr:outcomeId>5432b93b99c149.32220768</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2005-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Influenced design of HeartSpare 1B clinical study</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>72B789C8-79AF-466E-AC0C-5920AD920B86</gtr:id><gtr:impact>HeartSpare 1B
Phase 3 randomised trial of voluntary breath-hold technique and prone radiotherapy.

Recruitment completed and results published

Bartlett FR, Colgan RM, Donovan EM, et al. The UK HeartSpare study (Stage 1B): Randomised comparison of voluntary breath-hold technique and prone radiotherapy after breast conserving surgery. Radioth Oncol 2015; 114: 66-72.

Darby SD, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Br&amp;oslash;nnum D, Correa C, Cutter D, Gagliardi G, Gigante B, Jensen MB, Nisbet A, Peto R, Rahimi K, Taylor C, Hall P. Risk of ischemic heart disease in women irradiated for breast cancer. New England Journal of Medicine 2013;368:987-998

Our dose-response relationship for ischaemic heart disease after radiotherapy showed there was no evidence of a threshold heart dose below which there was no risk. The study was set up to investigate ways of reducing heart dose as much as possible in left breast radiotherapy.</gtr:impact><gtr:outcomeId>56d6c70d91cd19.25546664</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Practice guidelines for European Society of Cardiology</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:guidelineTitle>2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)</gtr:guidelineTitle><gtr:id>EC0B72D7-12B9-4D5C-90CA-337AF0E388AF</gtr:id><gtr:outcomeId>58ba87d8b777a4.81776298</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>https://www.ncbi.nlm.nih.gov/pubmed/27567406</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Our work was used to assess the risk of heart disease after radiotherapy in &amp;quot;Follow-up after treatment for breast cancer Practical guide to survivorship care for family physicians&amp;quot;</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:guidelineTitle>Follow-up after treatment for breast cancer Practical guide to survivorship care for family physicians</gtr:guidelineTitle><gtr:id>831B2783-6AE2-4FF1-912F-D31E2FA4BBB5</gtr:id><gtr:outcomeId>58ba8cb7b4cba4.29770806</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>http://www.cfp.ca/content/62/10/805.short</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation in a Guideline Update from the American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update</gtr:guidelineTitle><gtr:id>6EE11122-70E5-41BA-8449-D64920FA6EF3</gtr:id><gtr:impact>Our research has influenced which women receive radiotherapy following mastectomy for an invasive breast cancer</gtr:impact><gtr:outcomeId>58bd864b88a315.09315199</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>https://link.springer.com/article/10.1245/s10434-016-5558-8</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Our work on the main risks of breast cancer radiotherapy (second cancer and heart disease) was used by the Clinical Translational Radiotherapy working group (CTRad) to inform the UK internal mammary chain research agenda.</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>2CCB8BA0-E482-429A-B57E-1B123CF16A91</gtr:id><gtr:outcomeId>58ba8db640f801.70076552</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation in National Clinical Practice Guidelines in Oncology 2016</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:guidelineTitle>Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology</gtr:guidelineTitle><gtr:id>B42CE739-3C11-4568-924D-437F0DD7FA09</gtr:id><gtr:outcomeId>58ba8a2e829886.14447844</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>http://www.jnccn.org/content/14/3/324.short</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Our work was used to assess the risk of heart disease after radiotherapy in &amp;quot;Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline&amp;quot;</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:guidelineTitle>Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline</gtr:guidelineTitle><gtr:id>08799927-3915-453D-B0DB-66A4BCE3548A</gtr:id><gtr:outcomeId>58ba8c2b2afaf0.88317905</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>http://ascopubs.org/doi/abs/10.1200/JCO.2016.70.5400</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Influenced design of proton beam therapy in breast cancer study</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7701FA13-BC8A-4D22-89F8-904B21EC60D1</gtr:id><gtr:impact>Proton beam therapy in breast cancer clinical study
Study being designed.
Darby SD, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Br&amp;oslash;nnum D, Correa C, Cutter D, Gagliardi G, Gigante B, Jensen MB, Nisbet A, Peto R, Rahimi K, Taylor C, Hall P. Risk of ischemic heart disease in women irradiated for breast cancer. New England Journal of Medicine 2013;368:987-998
The design of this study requires absolute estimates of the likely cardiac risks of breast cancer radiotherapy for included women. These will be calculated using Darby 2013.
It also requires estimates of the risks for young women, and for women who also receive cardiotoxic chemotherapy, which will be informed by our other projects.</gtr:impact><gtr:outcomeId>56d6c88d856680.10454359</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:guidelineTitle>Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)</gtr:guidelineTitle><gtr:id>CD7D1661-9B2B-445F-ABF9-8E740A2D4C2D</gtr:id><gtr:impact>This article has clarified the importance of obtaining information on the hormonal receptor status for women with breast cancer before deciding on the best course of treatment for them</gtr:impact><gtr:outcomeId>58bd952bbb4263.40533995</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>http://www.ejcancer.com/article/S0959-8049(17)30075-8/abstract</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300 000 women in US SEER cancer registries</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:guidelineTitle>London Cancer Alliance</gtr:guidelineTitle><gtr:id>D1CBAC9A-497E-43A1-A36D-54FEC33F9720</gtr:id><gtr:impact>Our dose-response relationship, and our work on the relationship between maximum heart distance and mean heart dose were used to inform the London Cancer Alliance guidelines for heart sparing breast cancer radiotherapy (10th July 2014).</gtr:impact><gtr:outcomeId>56d5c20f30bda8.89569021</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>DEGRO (ie German Association for Radiation Oncology) practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:guidelineTitle>DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences</gtr:guidelineTitle><gtr:id>5AA60208-A2D0-4B11-A1E9-1F83101955BB</gtr:id><gtr:impact>Our article provided quantitative information regarding the beneficial effect of radiotherapy following surgery for early breast cancer.</gtr:impact><gtr:outcomeId>58bd8f5b6dce30.56171824</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>https://link.springer.com/article/10.1007/s00066-015-0939-7</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Our systematic review of heart doses in breast cancer was quoted by: Sardar, P 2016. &amp;quot;Long-term cardiovascular mortality after radiotherapy for breast cancer: A systematic review and meta-analysis&amp;quot;. DOI: 10.1002/clc.22631</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:id>0A711EC4-28F4-4E4F-8756-01F65F2E7242</gtr:id><gtr:outcomeId>58ba8f841cdbb1.32950106</gtr:outcomeId><gtr:type>Citation in systematic reviews</gtr:type><gtr:url>http://onlinelibrary.wiley.com/doi/10.1002/clc.22631/full</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:guidelineTitle>DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences</gtr:guidelineTitle><gtr:id>DCE722B1-C210-469D-89AE-541893BBC6AD</gtr:id><gtr:impact>Our article provided quantitative information on the benefits of radiotherapy for women with early breast cancer</gtr:impact><gtr:outcomeId>58bd92821b6934.42819550</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>https://link.springer.com/article/10.1007/s00066-015-0939-7</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Risk of ischemic heart disease in women irradiated for breast cancer II</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:guidelineTitle>Risk of ischemic heart disease in women irradiated for breast cancer</gtr:guidelineTitle><gtr:id>A66BAB1F-A0AD-43CD-B284-DB50290E0A70</gtr:id><gtr:impact>Results were used to inform the DEGRO (German society of radiation oncology) guidelines 2014 and 2015.

DEGRO practical guidelines: radiotherapy of breast cancer III - radiotherapy of lymphatic pathways
Strahlenther Onkol 2014; 190: 342-352.

DEGRO practical guidelines for radiotherapy of breast cancer V - therapy for locally advanced and inflammatory breast cancer
Strahlenther Onkol 2015; 191: 623-33.</gtr:impact><gtr:outcomeId>56d5c522bc1ca8.48699279</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Influenced design of HeartSpare 2 clinical study</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C6C865CB-5EA1-447A-9CB1-915C91F3B100</gtr:id><gtr:impact>HeartSpare 2
The aim of this study was to make heart-sparing breast radiotherapy available to all suitable patients across the NHS.

Recruitment completed. Results not yet published

Darby SD, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Br&amp;oslash;nnum D, Correa C, Cutter D, Gagliardi G, Gigante B, Jensen MB, Nisbet A, Peto R, Rahimi K, Taylor C, Hall P. Risk of ischemic heart disease in women irradiated for breast cancer. New England Journal of Medicine 2013;368:987-998

Our dose-response relationship for ischaemic heart disease after radiotherapy showed there was no evidence of a threshold heart dose below which there was no risk. The study was set up to reduce heart dose from left breast radiotherapy throughout the UK.</gtr:impact><gtr:outcomeId>56d6c7a0cc8b67.51766702</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Risk of ischemic heart disease in women irradiated for breast cancer</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>Expert Consensus for Multi-Modality Imaging Evaluation of Cardiovascular Complications of Radiotherapy in Adults: A Report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography . Journal of the American Society of Echocardiography 2013; 26: 1013-1032</gtr:guidelineTitle><gtr:id>316AE2C0-7B5C-40FC-9778-E46CBDF4A0EE</gtr:id><gtr:outcomeId>56d5c45060b207.33673768</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Influenced design of HeartSpare-plus clinical study</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E5AE94CA-4CFB-437F-B792-A682C4FBF2EC</gtr:id><gtr:impact>HeartSpare-plus
This study aims to identify optimal radiotherapy techniques for treating locoregional lymph nodes in women whilst limiting the dose to normal tissues, in order to reduce the risks of radiation-induced heart disease and second cancers.
Darby SD, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Br&amp;oslash;nnum D, Correa C, Cutter D, Gagliardi G, Gigante B, Jensen MB, Nisbet A, Peto R, Rahimi K, Taylor C, Hall P. Risk of ischemic heart disease in women irradiated for breast cancer. New England Journal of Medicine 2013;368:987-998
Our dose-response relationship for ischaemic heart disease after radiotherapy showed there was no evidence of a threshold heart dose below which there was no risk. The study was set up to reduce heart dose from left regional node irradiation.</gtr:impact><gtr:outcomeId>56d6c8177cf873.14442766</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation in European Society of Cardiology</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>48E66503-1DA5-4CBA-947C-A786F1D62FF7</gtr:id><gtr:impact>Our work on the cardiovascular risks of radiotherapy for breast cancer have provided quantitative information that has been used in this position paper from the European Society of Cardiology</gtr:impact><gtr:outcomeId>58bd9caf68bcc6.44888209</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>https://academic.oup.com/eurheartj/article-abstract/37/36/2768/2197413/2016-ESC-Position-Paper-on-cancer-treatments-and?redirectedFrom=fulltext</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Influenced design of HeartSpare 1A clinical study</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7B0D9DD6-4723-461F-BBDB-DAE9AA18DCED</gtr:id><gtr:impact>Clinical Study
HeartSpare 1A 
Phase 3 randomised trial of voluntary deep-inspiratory breast hold versus active breathing control deep-inspiration breath hold with active breathing control.

Recruitment completed and results published

Bartlett FR, Colgan RM, Carr K, et al. The UK HeartSpare study: Randomised evaluation of voluntary deep-inspiratory breath-hold in women undergoing breast radiotherapy. Radioth Oncol 2013; 108: 242-7.

Research paper from our team used in study design
Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300 000 women in US SEER cancer registries. Lancet Oncol 2005;6:557-565.

Impact of research
Our work on heart disease after breast cancer radiotherapy highlighted the need for breast cancer radiotherapy that avoided the heart.</gtr:impact><gtr:outcomeId>56d6c6b2d0c051.83767744</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Influence on Japanese</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:guidelineTitle>The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2015 edition</gtr:guidelineTitle><gtr:id>A60FD925-CFED-46AC-A597-8D748BEAE431</gtr:id><gtr:impact>Our article provided quantitative information on the benefits and risks of radiotherapy for women with breast cancer</gtr:impact><gtr:outcomeId>58bd8aa637e433.69504240</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>https://link.springer.com/article/10.1007/s12282-016-0672-9</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Cardiac side-effects from breast cancer radiotherapy</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:guidelineTitle>Royal College of Radiologists guidelines</gtr:guidelineTitle><gtr:id>BE504CDF-540E-43F9-8A4A-A86DEF813F47</gtr:id><gtr:outcomeId>56d5c2c2a02491.38499563</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Inferring the effects of cancer treatment: Divergent results from Early Breast Cancer Trialists' Collaborative Group meta-analyses of randomized trials and observational data from SEER registries</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3B4D8647-2F43-46A8-ADE9-01B202BEFDC3</gtr:id><gtr:outcomeId>56d5c0b10dd126.04200941</gtr:outcomeId><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Estimating cardiac exposure from breast cancer radiotherapy in clinical practice</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:guidelineTitle>Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO clinical practice guidelines</gtr:guidelineTitle><gtr:id>54F4E4E8-2ECB-4BB5-8541-71745A5DC014</gtr:id><gtr:impact>Results were used to inform the following clinical practice guidelines:

Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO clinical practice guidelines. Ann Oncol 2010; 21 (Suppl 5) v277-v282.</gtr:impact><gtr:outcomeId>56d5c5aac31d06.21547952</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>This cardiac atlas enables reproducible contouring of segments of the left ventricle and main coronary arteries to facilitate future studies relating cardiac radiation doses to clinical outcomes.</gtr:description><gtr:id>AEA16CFB-70EA-418F-829E-AE05025615CE</gtr:id><gtr:impact>The heart is a complex anatomical organ and contouring the cardiac substructures is challenging. We have provided a reproducible method for contouring left ventricular and coronary arterial segments on radiotherapy CT-planning scans.</gtr:impact><gtr:outcomeId>58bd9ecd80f9c4.28994603</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Cardiac Contouring Atlas</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:url>http://www.thegreenjournal.com/article/S0167-8140(17)30030-0/abstract</gtr:url><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2FC535A5-05BB-4FE6-934B-E754B4CE3EAD</gtr:id><gtr:title>Can Observational Data Replace Randomized Trials?</gtr:title><gtr:parentPublicationTitle>Journal of clinical oncology : official journal of the American Society of Clinical Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49ef9a33f770ff0ab5f2f1190e9faa2b"><gtr:id>49ef9a33f770ff0ab5f2f1190e9faa2b</gtr:id><gtr:otherNames>McGale P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0732-183X</gtr:issn><gtr:outcomeId>58ac63d27f5622.23960780</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>110AB7BE-046B-4C2D-9834-BF3492C88139</gtr:id><gtr:title>Exposure of the Heart in Breast Cancer Radiation Therapy: A Systematic Review of Heart Doses Published During 2003 to 2013.</gtr:title><gtr:parentPublicationTitle>International journal of radiation oncology, biology, physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5744e4525dbbbd191086257ec769aab"><gtr:id>a5744e4525dbbbd191086257ec769aab</gtr:id><gtr:otherNames>Taylor CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0360-3016</gtr:issn><gtr:outcomeId>56d99502a11722.23757071</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C018B640-2D87-4885-9E32-CCF5AD43766B</gtr:id><gtr:title>Metal artefact reduction for accurate tumour delineation in radiotherapy.</gtr:title><gtr:parentPublicationTitle>Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/adc2d0993b6032db2ab767e4827823f1"><gtr:id>adc2d0993b6032db2ab767e4827823f1</gtr:id><gtr:otherNames>Kovacs DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0167-8140</gtr:issn><gtr:outcomeId>5a9686e5a7d6c7.47209896</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D438319-9294-4A0C-BE3C-D8E2A9E5A51D</gtr:id><gtr:title>Report on the international colloquium on cardio-oncology (rome, 12-14 march 2014).</gtr:title><gtr:parentPublicationTitle>Ecancermedicalscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b1f77321e569bfe84f0a999aa85d8e6"><gtr:id>8b1f77321e569bfe84f0a999aa85d8e6</gtr:id><gtr:otherNames>Ewer M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1754-6605</gtr:issn><gtr:outcomeId>541ffa55abea94.39851322</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8826D05-C1FC-459D-A3CC-6DED1181DE05</gtr:id><gtr:title>Risks of heart disease after radiotherapy.</gtr:title><gtr:parentPublicationTitle>Texas Heart Institute journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1499c3cc06b6083b22f1264ce6ab8d0c"><gtr:id>1499c3cc06b6083b22f1264ce6ab8d0c</gtr:id><gtr:otherNames>Cutter DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0730-2347</gtr:issn><gtr:outcomeId>541ff9b1e3f336.83313311</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A47585E3-3710-442A-B198-1BB899CEBCF4</gtr:id><gtr:title>Cardiac doses from Swedish breast cancer radiotherapy since the 1950s.</gtr:title><gtr:parentPublicationTitle>Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5744e4525dbbbd191086257ec769aab"><gtr:id>a5744e4525dbbbd191086257ec769aab</gtr:id><gtr:otherNames>Taylor CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0167-8140</gtr:issn><gtr:outcomeId>541ff9b45d4802.77888509</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35085DE4-CB13-4AFC-93EA-5AAFEC127F36</gtr:id><gtr:title>Incidentally Raised Cardiac Troponin I Has a Worse Prognosis in Older Patients Compared to Those with Normal Cardiac Troponin I and Patients with Acute Coronary Syndrome: A Cohort Study.</gtr:title><gtr:parentPublicationTitle>Gerontology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dac36b85a5a64e9ed5ef42a68fc76e77"><gtr:id>dac36b85a5a64e9ed5ef42a68fc76e77</gtr:id><gtr:otherNames>Mannu GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0304-324X</gtr:issn><gtr:outcomeId>59ccf2a32c3d97.91562254</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5897CD08-ABEF-4C43-983F-3B3F609DD781</gtr:id><gtr:title>Prognostic value of coronary revascularisation-related myocardial injury: a cardiac magnetic resonance imaging study.</gtr:title><gtr:parentPublicationTitle>Heart (British Cardiac Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d8404ff0e6986f0acd9bc29d37881a4"><gtr:id>4d8404ff0e6986f0acd9bc29d37881a4</gtr:id><gtr:otherNames>Rahimi K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1355-6037</gtr:issn><gtr:outcomeId>541ff9b37bf190.63351229</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48A5713B-0DF7-4450-BBDA-727AC8FF7EB2</gtr:id><gtr:title>OECI Workshop on late side-effects of cancer treatments.</gtr:title><gtr:parentPublicationTitle>European journal of cancer (Oxford, England : 1990)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03ff7b857f3d5dba6b06a6512300297c"><gtr:id>03ff7b857f3d5dba6b06a6512300297c</gtr:id><gtr:otherNames>Arriagada R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0959-8049</gtr:issn><gtr:outcomeId>541ff9b4212290.94448876</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4D839EE-45F7-483E-9006-F1CCF71E597B</gtr:id><gtr:title>20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ca035eaffebd45bbb1ea7f5ec2d0e2e"><gtr:id>5ca035eaffebd45bbb1ea7f5ec2d0e2e</gtr:id><gtr:otherNames>Pan H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>5a9686e6bae0f2.92970002</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>979F3CAA-9516-4C9F-8BDA-CFAF83E30545</gtr:id><gtr:title>SU-F-BRD-04: Robustness Analysis of Proton Breast Treatments Using An Alpha-Stable Distribution Parameterization</gtr:title><gtr:parentPublicationTitle>Medical Physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef923ba6322e107b6e0f799f95b363c3"><gtr:id>ef923ba6322e107b6e0f799f95b363c3</gtr:id><gtr:otherNames>Van den Heuvel F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56d995027b4c67.30739876</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC7B58E6-C202-40B8-99E0-3869EE38C05F</gtr:id><gtr:title>Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma.</gtr:title><gtr:parentPublicationTitle>Journal of clinical oncology : official journal of the American Society of Clinical Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c259ecef77811124a2cb4f01acdba0b0"><gtr:id>c259ecef77811124a2cb4f01acdba0b0</gtr:id><gtr:otherNames>van Nimwegen FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0732-183X</gtr:issn><gtr:outcomeId>56d99502c60f99.43240407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1051AB6-71E0-4F23-8F65-79DD4A3DA81E</gtr:id><gtr:title>Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f88cc0b3857e4454158c5b9ddf455220"><gtr:id>f88cc0b3857e4454158c5b9ddf455220</gtr:id><gtr:otherNames>Wang H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474547X</gtr:issn><gtr:outcomeId>58bd3dff806105.87019951</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12A95DDA-1E3A-4D74-B3F2-22DE43393B2C</gtr:id><gtr:title>2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).</gtr:title><gtr:parentPublicationTitle>European journal of heart failure</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dca4cf8146da46491f7c1555a8b028b9"><gtr:id>dca4cf8146da46491f7c1555a8b028b9</gtr:id><gtr:otherNames>Zamorano JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1388-9842</gtr:issn><gtr:outcomeId>58ac644f8d40a4.83598410</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B10908D0-0FB9-47F2-B0F8-6F119E00DB53</gtr:id><gtr:title>Measurement error in the explanatory variable of a binary regression: regression calibration and integrated conditional likelihood in studies of residential radon and lung cancer.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/382df3182ce999d2ef4f940be47b3378"><gtr:id>382df3182ce999d2ef4f940be47b3378</gtr:id><gtr:otherNames>Fearn T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>541ff9b53d05b0.38380730</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBC5F064-D896-4C42-93C7-4DDE9E9AB927</gtr:id><gtr:title>Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials</gtr:title><gtr:parentPublicationTitle>The Lancet Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c24e347a951d222b260ac94aa4746ba3"><gtr:id>c24e347a951d222b260ac94aa4746ba3</gtr:id><gtr:otherNames>Asselain B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5a967b5315d114.24225016</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DCE62FDE-0305-4F96-9CE8-E27DCE099F84</gtr:id><gtr:title>Dose and Fractionation in Radiation Therapy of Curative Intent for Non-Small Cell Lung Cancer: Meta-Analysis of Randomized Trials.</gtr:title><gtr:parentPublicationTitle>International journal of radiation oncology, biology, physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ce1ebc7d270324d697e233b960aa595"><gtr:id>8ce1ebc7d270324d697e233b960aa595</gtr:id><gtr:otherNames>Ramroth J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0360-3016</gtr:issn><gtr:outcomeId>58ac63d24b0de9.98775600</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C471F7E-018D-4342-8301-2B06DB2EAE75</gtr:id><gtr:title>Life years lost attributable to late effects after radiotherapy for early stage Hodgkin lymphoma: The impact of proton therapy and/or deep inspiration breath hold.</gtr:title><gtr:parentPublicationTitle>Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20ac62947b812a20e716a3d6628e275b"><gtr:id>20ac62947b812a20e716a3d6628e275b</gtr:id><gtr:otherNames>Rechner LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0167-8140</gtr:issn><gtr:outcomeId>59ccf1ebaef388.67959320</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A74AFA1-DBDE-4195-92EE-115F1265830B</gtr:id><gtr:title>Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c259ecef77811124a2cb4f01acdba0b0"><gtr:id>c259ecef77811124a2cb4f01acdba0b0</gtr:id><gtr:otherNames>van Nimwegen FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>58b857fb14a816.31244990</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F85C70B8-27D5-45E8-ADE0-D2785B1AC04F</gtr:id><gtr:title>Making progress in early breast cancer: Taking time or accepting risk?</gtr:title><gtr:parentPublicationTitle>European journal of cancer (Oxford, England : 1990)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dac36b85a5a64e9ed5ef42a68fc76e77"><gtr:id>dac36b85a5a64e9ed5ef42a68fc76e77</gtr:id><gtr:otherNames>Mannu GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0959-8049</gtr:issn><gtr:outcomeId>59ccf2a2c60fe5.32860459</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD47E746-5819-42C3-89E4-93A3866A80EA</gtr:id><gtr:title>12. Cancers in 2010 attributable to ionising radiation exposure in the UK.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29ad015500f752ab405d4930cd680bb1"><gtr:id>29ad015500f752ab405d4930cd680bb1</gtr:id><gtr:otherNames>Parkin DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>541ff9b17aacc9.48594389</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B0CA963-C597-4209-B4E7-48E4EE021455</gtr:id><gtr:title>Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015</gtr:title><gtr:parentPublicationTitle>LANCET</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24a33d7ea5225d5305af38f6da330900"><gtr:id>24a33d7ea5225d5305af38f6da330900</gtr:id><gtr:otherNames>Wang Haidong</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>58bd3ea9214ae3.72663547</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DDEBAE9-AEED-44E7-9E1E-163BE174E870</gtr:id><gtr:title>Cumulative burden of disease: a relevant measure of the late side-effects of cancer treatment</gtr:title><gtr:parentPublicationTitle>The Lancet Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/622d974964967da2e13cb4fc60b449aa"><gtr:id>622d974964967da2e13cb4fc60b449aa</gtr:id><gtr:otherNames>Aznar M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>14745488</gtr:issn><gtr:outcomeId>58bd3e00787355.47632436</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87F30AE5-4ED4-4033-BE08-7F5A7C7E795F</gtr:id><gtr:title>Cardiac Mortality Among 200 000 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age: The Teenage and Young Adult Cancer Survivor Study.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/231135a2757176eadcd69d3b880505c2"><gtr:id>231135a2757176eadcd69d3b880505c2</gtr:id><gtr:otherNames>Henson KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>58bd3c781e2719.14352428</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2FE1383D-505D-43FD-9CE6-5E71103A03C6</gtr:id><gtr:title>Cardiovascular disease after cancer therapy.</gtr:title><gtr:parentPublicationTitle>EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.]</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6aeeeefac02ebaad070b5589a6c0a08"><gtr:id>a6aeeeefac02ebaad070b5589a6c0a08</gtr:id><gtr:otherNames>Aleman BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1359-6349</gtr:issn><gtr:outcomeId>541ffa568b4516.94656344</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F80CCC75-FD87-43D2-BAB3-7D46227FA8EC</gtr:id><gtr:title>Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c259ecef77811124a2cb4f01acdba0b0"><gtr:id>c259ecef77811124a2cb4f01acdba0b0</gtr:id><gtr:otherNames>van Nimwegen FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>5a9686e4ceb571.31064080</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A2E050F-C208-4B5A-876B-3149ADCA34B0</gtr:id><gtr:title>Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee.</gtr:title><gtr:parentPublicationTitle>International journal of radiation oncology, biology, physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/377f5a63c931a1bd4fe0c8358929103f"><gtr:id>377f5a63c931a1bd4fe0c8358929103f</gtr:id><gtr:otherNames>Tseng YD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0360-3016</gtr:issn><gtr:outcomeId>5a9686e50b70c0.03664103</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2C85A99-1756-4AB9-A1EF-80E710D2C2A4</gtr:id><gtr:title>E4. Current clinical issues in breast cancer</gtr:title><gtr:parentPublicationTitle>European Journal of Cancer Supplements</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81c3506aca48dd2c15e96e0638a63d57"><gtr:id>81c3506aca48dd2c15e96e0638a63d57</gtr:id><gtr:otherNames>Poortmans P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>541ffa54349b94.30535080</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18F18B9B-C868-43E7-945C-CE02D4AD1568</gtr:id><gtr:title>Risk stratification of childhood cancer survivors necessary for evidence-based clinical long-term follow-up.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cee65097af304873892f700751f8af1"><gtr:id>5cee65097af304873892f700751f8af1</gtr:id><gtr:otherNames>Frobisher C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>5a9686e61cf4d4.84999967</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB333AF4-FAD8-4130-8507-B663355D256B</gtr:id><gtr:title>Rheumatic Mitral Valve Disease Is Associated With Worse Outcomes in Stroke: A Thailand National Database Study.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/655e65ba6d998b3f12448d9ace4ca067"><gtr:id>655e65ba6d998b3f12448d9ace4ca067</gtr:id><gtr:otherNames>Wood AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>59ccf2a3061d13.74876259</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95DD9F28-8480-49BD-A3F1-CAD161035CA2</gtr:id><gtr:title>Cardiac dose from tangential breast cancer radiotherapy in the year 2006.</gtr:title><gtr:parentPublicationTitle>International journal of radiation oncology, biology, physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5744e4525dbbbd191086257ec769aab"><gtr:id>a5744e4525dbbbd191086257ec769aab</gtr:id><gtr:otherNames>Taylor CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0360-3016</gtr:issn><gtr:outcomeId>541ff9b5086282.14539164</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4B4FD23-F42D-4F37-A518-7BAD33E01527</gtr:id><gtr:title>&amp;quot;To clip or not to clip. That is no question!&amp;quot;</gtr:title><gtr:parentPublicationTitle>European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c8216b56f74db4159b05d72a308c00b"><gtr:id>5c8216b56f74db4159b05d72a308c00b</gtr:id><gtr:otherNames>Aznar MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0748-7983</gtr:issn><gtr:outcomeId>59ccf1ebd35d26.20047061</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CAAABEF-5F5B-4226-965C-AD6A83AD074C</gtr:id><gtr:title>Long-term hospitalisation rates among 5-year survivors of Hodgkin lymphoma in adolescence or young adulthood: A nationwide cohort study.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a54c47d52c0e3728bc9ddff490b61e0"><gtr:id>5a54c47d52c0e3728bc9ddff490b61e0</gtr:id><gtr:otherNames>Rugbjerg K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>58b857fac38098.30049397</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFC6D94F-0E78-4996-93D2-26A51BD0A011</gtr:id><gtr:title>FLT-PET for early response evaluation of colorectal cancer patients with liver metastases: a prospective study.</gtr:title><gtr:parentPublicationTitle>EJNMMI research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5e5adafb0db32f7a1836a6b63cae68d"><gtr:id>c5e5adafb0db32f7a1836a6b63cae68d</gtr:id><gtr:otherNames>Mogensen MB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>59ccf1ec2252f3.06741007</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C254C82A-3786-4297-8E64-BFB486B9FDC0</gtr:id><gtr:title>Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel.</gtr:title><gtr:parentPublicationTitle>Cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d586d32a79d6c2c78ba0989e57ae17c5"><gtr:id>d586d32a79d6c2c78ba0989e57ae17c5</gtr:id><gtr:otherNames>Kaufmann M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0008-543X</gtr:issn><gtr:outcomeId>541ff9b3198b63.18912421</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC3084CA-4FFE-4B20-A81C-381CF866CF80</gtr:id><gtr:title>Long-term hospitalisation rates among 5-year survivors of Hodgkin lymphoma in adolescence or young adulthood: A nationwide cohort study.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a54c47d52c0e3728bc9ddff490b61e0"><gtr:id>5a54c47d52c0e3728bc9ddff490b61e0</gtr:id><gtr:otherNames>Rugbjerg K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>5a9686e5448535.82062315</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D642D6F9-D9BB-46CD-AD78-777FFBAC82D5</gtr:id><gtr:title>Population-Based Long-Term Cardiac-Specific Mortality Among 34 489 Five-Year Survivors of Childhood Cancer in Great Britain.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/048991b54aa7f04bcf580e9c2e0ee9a9"><gtr:id>048991b54aa7f04bcf580e9c2e0ee9a9</gtr:id><gtr:otherNames>Fidler MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>5a9686e65d5063.23824387</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4495191-4DA8-4BF6-88B4-67DBE6A124E5</gtr:id><gtr:title>The role of technology in clinical trials using stereotactic body radiotherapy.</gtr:title><gtr:parentPublicationTitle>The British journal of radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/622d974964967da2e13cb4fc60b449aa"><gtr:id>622d974964967da2e13cb4fc60b449aa</gtr:id><gtr:otherNames>Aznar M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0007-1285</gtr:issn><gtr:outcomeId>5a967b52acadc8.63627037</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>218336E5-0326-4916-8022-6E8B400A0CF0</gtr:id><gtr:title>The cancer burden in the United Kingdom in 2007 due to radiotherapy.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5bd8cbd6e03ab45b6cd324c79ca4196b"><gtr:id>5bd8cbd6e03ab45b6cd324c79ca4196b</gtr:id><gtr:otherNames>Maddams J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>541ff9b2224348.98213389</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>871614E4-0D33-4F40-86BE-813DE75E3A95</gtr:id><gtr:title>A Dose-response Relationship for the Incidence of Radiation-related Heart Disease</gtr:title><gtr:parentPublicationTitle>International Journal of Radiation Oncology*Biology*Physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f69551d9c96ceb037d387cf751a53042"><gtr:id>f69551d9c96ceb037d387cf751a53042</gtr:id><gtr:otherNames>Darby S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>541ffa55e3fd21.26736206</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3FC16693-E178-40A4-952C-FE9FF3783DB5</gtr:id><gtr:title>2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dca4cf8146da46491f7c1555a8b028b9"><gtr:id>dca4cf8146da46491f7c1555a8b028b9</gtr:id><gtr:otherNames>Zamorano JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>58ac644fdaa730.04665906</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69069FC7-7D2F-4D3E-92B2-632BE70F47B4</gtr:id><gtr:title>Uncertainties in estimating heart doses from 2D-tangential breast cancer radiotherapy.</gtr:title><gtr:parentPublicationTitle>Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6174e0b2ba42d94aa0729354c743671f"><gtr:id>6174e0b2ba42d94aa0729354c743671f</gtr:id><gtr:otherNames>Lorenzen EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0167-8140</gtr:issn><gtr:outcomeId>58ba7ebdafdb11.49253509</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE1C29B8-B66A-42E7-9708-038BD1A02FDF</gtr:id><gtr:title>Risk of heart disease in relation to radiotherapy and chemotherapy with anthracyclines among 19,464 breast cancer patients in Denmark, 1977-2005.</gtr:title><gtr:parentPublicationTitle>Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ff1faf4019e3677455f6fb0bda050d3"><gtr:id>1ff1faf4019e3677455f6fb0bda050d3</gtr:id><gtr:otherNames>Rehammar JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0167-8140</gtr:issn><gtr:outcomeId>5a9686e575cb58.85139826</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>990F3D6C-0881-4992-81E9-E25054DDD1AF</gtr:id><gtr:title>Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data.</gtr:title><gtr:parentPublicationTitle>Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c60c4f07b590f8fe1e7feacdba0e22e0"><gtr:id>c60c4f07b590f8fe1e7feacdba0e22e0</gtr:id><gtr:otherNames>Holyoake DLP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0167-8140</gtr:issn><gtr:outcomeId>5a9686e5daf714.50011527</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC0A8438-5000-4038-97F2-AB91965DE502</gtr:id><gtr:title>Inferring the Effects of Cancer Treatment: Divergent Results From Early Breast Cancer Trialists' Collaborative Group Meta-Analyses of Randomized Trials and Observational Data From SEER Registries (Retraction of vol 34, pg 803, 2016)</gtr:title><gtr:parentPublicationTitle>JOURNAL OF CLINICAL ONCOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69377317a74f15518cd5378864a7c6ec"><gtr:id>69377317a74f15518cd5378864a7c6ec</gtr:id><gtr:otherNames>McGale P.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0732-183X</gtr:issn><gtr:outcomeId>58bd3ea94be452.92787686</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99C924B0-B09A-4751-97FF-7354C8824521</gtr:id><gtr:title>Risk of ischemic heart disease in women after radiotherapy for breast cancer.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f41c6edcb079f6d80d43ed118bb8f8b3"><gtr:id>f41c6edcb079f6d80d43ed118bb8f8b3</gtr:id><gtr:otherNames>Darby SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>541c0884a0b987.74288813</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B84AB775-49B0-4CB5-87F3-FB59EADE74B4</gtr:id><gtr:title>Inter-observer variation in delineation of the heart and left anterior descending coronary artery in radiotherapy for breast cancer: a multi-centre study from Denmark and the UK.</gtr:title><gtr:parentPublicationTitle>Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6174e0b2ba42d94aa0729354c743671f"><gtr:id>6174e0b2ba42d94aa0729354c743671f</gtr:id><gtr:otherNames>Lorenzen EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0167-8140</gtr:issn><gtr:outcomeId>541ff9af9d6120.85824747</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6CE73F6A-7ECE-4EFD-88DE-DB753D974272</gtr:id><gtr:title>Estimating cardiac exposure from breast cancer radiotherapy in clinical practice.</gtr:title><gtr:parentPublicationTitle>International journal of radiation oncology, biology, physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5744e4525dbbbd191086257ec769aab"><gtr:id>a5744e4525dbbbd191086257ec769aab</gtr:id><gtr:otherNames>Taylor CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0360-3016</gtr:issn><gtr:outcomeId>541ff9b491ae53.73140926</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E40062A-1CAB-4F99-A688-2EF0241147A5</gtr:id><gtr:title>Reply to D. Vordermark and T. Pelz and R. Mazzola et al.</gtr:title><gtr:parentPublicationTitle>Journal of clinical oncology : official journal of the American Society of Clinical Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c259ecef77811124a2cb4f01acdba0b0"><gtr:id>c259ecef77811124a2cb4f01acdba0b0</gtr:id><gtr:otherNames>van Nimwegen FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0732-183X</gtr:issn><gtr:outcomeId>58bd3c78883660.04570543</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93849ACC-4FED-4B80-8578-577C21F1E1E2</gtr:id><gtr:title>Reproductive hormone analyses and effects of adjuvant zoledronic acid in early breast cancer - An AZURE (BIG 01/04) sub-study.</gtr:title><gtr:parentPublicationTitle>Journal of bone oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c690504953331fb806cb15021dc1c29b"><gtr:id>c690504953331fb806cb15021dc1c29b</gtr:id><gtr:otherNames>Wilson C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2212-1366</gtr:issn><gtr:outcomeId>5a9686e48c5ea9.03037878</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>994B819B-0003-4F67-B460-3BA199002543</gtr:id><gtr:title>Radiation-related heart disease: current knowledge and future prospects.</gtr:title><gtr:parentPublicationTitle>International journal of radiation oncology, biology, physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f41c6edcb079f6d80d43ed118bb8f8b3"><gtr:id>f41c6edcb079f6d80d43ed118bb8f8b3</gtr:id><gtr:otherNames>Darby SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0360-3016</gtr:issn><gtr:outcomeId>541ff9b2df15a8.63556155</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5BBE4479-2B65-4397-A191-05900C254E5D</gtr:id><gtr:title>Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8dbd9120b92f3f8653e21fa8425b50c7"><gtr:id>8dbd9120b92f3f8653e21fa8425b50c7</gtr:id><gtr:otherNames>EBCTCG (Early Breast Cancer Trialists' Collaborative Group)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>541c0882668cc1.84550903</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB3B51C3-D969-4242-81D8-ADF247523CC9</gtr:id><gtr:title>Ischemic heart disease and breast cancer radiotherapy: the way forward.</gtr:title><gtr:parentPublicationTitle>JAMA internal medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74e33b6e6c73fb34506ed6a3ffcaa967"><gtr:id>74e33b6e6c73fb34506ed6a3ffcaa967</gtr:id><gtr:otherNames>Taylor C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2168-6106</gtr:issn><gtr:outcomeId>541ff9af601d42.28727160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C8518A1-8E58-4EC3-8107-C30AC8B83DE3</gtr:id><gtr:title>Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial</gtr:title><gtr:parentPublicationTitle>The Lancet Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b53a8b255cc1ce15fcdb20bc91e6c946"><gtr:id>b53a8b255cc1ce15fcdb20bc91e6c946</gtr:id><gtr:otherNames>Earl H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a9686e749cdb4.17492801</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DAAB6B3-9950-46A7-B3B6-6DF440CE9F84</gtr:id><gtr:title>International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013).</gtr:title><gtr:parentPublicationTitle>Journal of the National Cancer Institute. Monographs</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e30a5e191e9021a5233d9f702398f649"><gtr:id>e30a5e191e9021a5233d9f702398f649</gtr:id><gtr:otherNames>Amoroso V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1052-6773</gtr:issn><gtr:outcomeId>56d9950257b621.32783878</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A10BDB9-B622-4C06-A697-3EB274B5D05D</gtr:id><gtr:title>Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dee784e8ecf4ee678a23ec291646c678"><gtr:id>dee784e8ecf4ee678a23ec291646c678</gtr:id><gtr:otherNames>Mathews JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>541ff9b025cf31.04895833</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC6CD123-559F-473C-9598-84630F8418B5</gtr:id><gtr:title>Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials.</gtr:title><gtr:parentPublicationTitle>Journal of clinical oncology : official journal of the American Society of Clinical Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74e33b6e6c73fb34506ed6a3ffcaa967"><gtr:id>74e33b6e6c73fb34506ed6a3ffcaa967</gtr:id><gtr:otherNames>Taylor C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0732-183X</gtr:issn><gtr:outcomeId>5a9686e68862a7.25076848</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDE484C3-6ADE-42DC-9C70-C4845B011AA5</gtr:id><gtr:title>A cardiac contouring atlas for radiotherapy.</gtr:title><gtr:parentPublicationTitle>Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83b2041e6cc42618f585a7f7b0c5c8e7"><gtr:id>83b2041e6cc42618f585a7f7b0c5c8e7</gtr:id><gtr:otherNames>Duane F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0167-8140</gtr:issn><gtr:outcomeId>5a9686e78129b4.25133098</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C2050E9-B899-43C1-A815-9F9B26A12EB0</gtr:id><gtr:title>Ischemic heart disease after breast cancer radiotherapy.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f41c6edcb079f6d80d43ed118bb8f8b3"><gtr:id>f41c6edcb079f6d80d43ed118bb8f8b3</gtr:id><gtr:otherNames>Darby SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>541ff9afdd7567.74860209</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BFF6E8E-B163-426D-B819-7186DDD3B943</gtr:id><gtr:title>Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/231135a2757176eadcd69d3b880505c2"><gtr:id>231135a2757176eadcd69d3b880505c2</gtr:id><gtr:otherNames>Henson KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>541ff9b06a5103.11154139</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5093C21C-2B71-46C0-ABA2-B8EEA0148F73</gtr:id><gtr:title>Effects of radiation therapy on the cardiovascular System</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eab98797b62286153cc4b65683c35baa"><gtr:id>eab98797b62286153cc4b65683c35baa</gtr:id><gtr:otherNames>Cutter, D.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>541ffe81889107.51038542</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>774B6EB0-0476-4955-BAA0-55FD02EC2A76</gtr:id><gtr:title>Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: on behalf of the Radiotherapy Committee of the EORTC lymphoma group.</gtr:title><gtr:parentPublicationTitle>Acta oncologica (Stockholm, Sweden)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c8216b56f74db4159b05d72a308c00b"><gtr:id>5c8216b56f74db4159b05d72a308c00b</gtr:id><gtr:otherNames>Aznar MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0284-186X</gtr:issn><gtr:outcomeId>5a967b52795100.46889266</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4798C734-45FF-4203-8AB9-9EA799E3F1C5</gtr:id><gtr:title>Commentary: A dose-response relationship for radiation-induced heart disease--current issues and future prospects.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49ef9a33f770ff0ab5f2f1190e9faa2b"><gtr:id>49ef9a33f770ff0ab5f2f1190e9faa2b</gtr:id><gtr:otherNames>McGale P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn><gtr:outcomeId>541ff9b4c9fcf8.74525386</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9DA8A37-4801-471C-BE86-C38D5B15194F</gtr:id><gtr:title>Simple method to estimate mean heart dose from Hodgkin lymphoma radiation therapy according to simulation X-rays.</gtr:title><gtr:parentPublicationTitle>International journal of radiation oncology, biology, physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c259ecef77811124a2cb4f01acdba0b0"><gtr:id>c259ecef77811124a2cb4f01acdba0b0</gtr:id><gtr:otherNames>van Nimwegen FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0360-3016</gtr:issn><gtr:outcomeId>56d995022a0cc5.69523521</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0BDD668-E5A0-4772-9755-D4ECCE0811B6</gtr:id><gtr:title>Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre.</gtr:title><gtr:parentPublicationTitle>Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ddd807d133c1c9bfe5074722d8f88a1"><gtr:id>5ddd807d133c1c9bfe5074722d8f88a1</gtr:id><gtr:otherNames>Haynes RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0931-0509</gtr:issn><gtr:outcomeId>541ff9b34ce6f3.59610486</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1D2CEEA-4373-4E57-9515-2F652E20C288</gtr:id><gtr:title>A cardiac contouring atlas for radiotherapy.</gtr:title><gtr:parentPublicationTitle>Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83b2041e6cc42618f585a7f7b0c5c8e7"><gtr:id>83b2041e6cc42618f585a7f7b0c5c8e7</gtr:id><gtr:otherNames>Duane F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0167-8140</gtr:issn><gtr:outcomeId>58bd3cc8667cd4.77437739</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07632105-E41C-43A8-BDCC-9726B5D41667</gtr:id><gtr:title>Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden.</gtr:title><gtr:parentPublicationTitle>Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49ef9a33f770ff0ab5f2f1190e9faa2b"><gtr:id>49ef9a33f770ff0ab5f2f1190e9faa2b</gtr:id><gtr:otherNames>McGale P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0167-8140</gtr:issn><gtr:outcomeId>541c0457a2aa59.91298574</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61F30271-126D-4201-A0F1-8F17AFA3BF9D</gtr:id><gtr:title>Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3028c3c895d8c1c989ada41a623a5519"><gtr:id>3028c3c895d8c1c989ada41a623a5519</gtr:id><gtr:otherNames>Forouzanfar M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474547X</gtr:issn><gtr:outcomeId>58bd3dffd3f011.13052683</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>415AC5F5-5F59-4919-BA6F-46F0EB3CA329</gtr:id><gtr:title>Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977-2001.</gtr:title><gtr:parentPublicationTitle>Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5744e4525dbbbd191086257ec769aab"><gtr:id>a5744e4525dbbbd191086257ec769aab</gtr:id><gtr:otherNames>Taylor CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0167-8140</gtr:issn><gtr:outcomeId>541ff9b269bcf0.88854804</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F035B23D-0E97-46A9-AADD-78D1894CCE88</gtr:id><gtr:title>Risk of Cerebrovascular Events in 178 962 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age: The TYACSS (Teenage and Young Adult Cancer Survivor Study).</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2dff72b1bebfda0fb1ab3f354786a890"><gtr:id>2dff72b1bebfda0fb1ab3f354786a890</gtr:id><gtr:otherNames>Bright CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>5a9686e7afc734.33475532</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17DAFF4A-6951-465D-8958-9754D248B972</gtr:id><gtr:title>Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial</gtr:title><gtr:parentPublicationTitle>The Lancet Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2924634446530babe86eb17d8c7d14b4"><gtr:id>2924634446530babe86eb17d8c7d14b4</gtr:id><gtr:otherNames>Coleman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a9686e7e0b4b2.75157243</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E418D9AB-58E2-4078-95EC-432A954D4F3D</gtr:id><gtr:title>Exposure of the lungs in breast cancer radiotherapy: A systematic review of lung doses published 2010-2015.</gtr:title><gtr:parentPublicationTitle>Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c8216b56f74db4159b05d72a308c00b"><gtr:id>5c8216b56f74db4159b05d72a308c00b</gtr:id><gtr:otherNames>Aznar MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0167-8140</gtr:issn><gtr:outcomeId>5a967b51eb36b5.65227374</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2F3C487-8813-4FBC-8A77-CD91B79A595A</gtr:id><gtr:title>Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015</gtr:title><gtr:parentPublicationTitle>LANCET</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d48127b90fa64f7cd1df1ea902349a68"><gtr:id>d48127b90fa64f7cd1df1ea902349a68</gtr:id><gtr:otherNames>Forouzanfar Mohammad H.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>58bd3ea8b89ae2.43421395</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6C056BD-24DD-4816-A880-B2BB5009687F</gtr:id><gtr:title>Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f83e29d9a58117c789a4393614d50fd4"><gtr:id>f83e29d9a58117c789a4393614d50fd4</gtr:id><gtr:otherNames>Early Breast Cancer Trialists' Collaborative Group (EBCTCG)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>541c0883a51034.91481675</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>023131A6-F556-482D-B8CF-4CE9E2FFDD4E</gtr:id><gtr:title>A modeling study of functional magnetic resonance imaging to individualize target definition of seminal vesicles for external beam radiotherapy.</gtr:title><gtr:parentPublicationTitle>Acta oncologica (Stockholm, Sweden)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/820ecee13665d423d5eb47c0cf4315f4"><gtr:id>820ecee13665d423d5eb47c0cf4315f4</gtr:id><gtr:otherNames>Damkj?r S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0284-186X</gtr:issn><gtr:outcomeId>5a967b52d73b84.94187399</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7139387F-5A94-4E9D-B9CD-6454CE92DCC0</gtr:id><gtr:title>Risk of valvular heart disease after treatment for Hodgkin lymphoma.</gtr:title><gtr:parentPublicationTitle>Journal of the National Cancer Institute</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1499c3cc06b6083b22f1264ce6ab8d0c"><gtr:id>1499c3cc06b6083b22f1264ce6ab8d0c</gtr:id><gtr:otherNames>Cutter DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8874</gtr:issn><gtr:outcomeId>56d99501e08c84.45192781</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B9DC66F-1E5C-4303-B188-675B77EB30F1</gtr:id><gtr:title>Exposure of the Lungs in Breast Cancer Radiation Therapy: A Systematic Review of Lung Doses Published Between 2010 and 2015</gtr:title><gtr:parentPublicationTitle>INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a475f5ed40084e147ff36f5dbe796686"><gtr:id>a475f5ed40084e147ff36f5dbe796686</gtr:id><gtr:otherNames>Aznar M. C.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0360-3016</gtr:issn><gtr:outcomeId>58bd3ea8e58df9.96569034</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U137686858</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>6FFAED28-939F-4795-9FD1-98511549B3B8</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>6.5  Radiotherapy</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>